| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.92B | 101.01B | 92.33B | 94.51B | 76.09B | 62.85B |
| Gross Profit | 22.40B | 21.26B | 17.92B | 19.21B | 17.98B | 14.96B |
| EBITDA | 6.10B | 5.63B | 3.06B | 5.22B | 5.44B | 4.93B |
| Net Income | 791.00M | 763.00M | -1.16B | 885.73M | 1.75B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 101.00B | 100.04B | 98.58B | 92.44B | 78.91B | 69.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 4.75B | 6.85B | 6.30B | 6.63B | 3.48B |
| Total Debt | 42.03B | 42.56B | 39.37B | 33.67B | 21.50B | 17.68B |
| Total Liabilities | 64.06B | 62.03B | 57.70B | 51.62B | 38.80B | 31.95B |
| Stockholders Equity | 36.27B | 37.33B | 37.22B | 37.10B | 36.74B | 34.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 684.00M | -3.08B | -4.80B | -22.99M | 712.74M |
| Operating Cash Flow | 0.00 | 6.14B | 353.00M | -466.24M | 2.83B | 3.01B |
| Investing Cash Flow | 0.00 | -4.98B | -3.20B | -6.65B | -3.44B | -1.86B |
| Financing Cash Flow | 0.00 | -3.67B | 2.90B | 7.66B | 2.11B | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥17.57B | 13.11 | ― | 4.07% | 18.02% | 18.04% | |
71 Outperform | ¥25.66B | 10.19 | ― | 3.64% | -1.44% | -1.26% | |
66 Neutral | ¥17.11B | 9.04 | ― | 3.27% | 13.09% | 89.45% | |
66 Neutral | ¥16.32B | 11.70 | ― | 2.70% | 1.30% | -5.03% | |
66 Neutral | ¥21.67B | 20.86 | ― | 4.66% | 7.19% | ― | |
64 Neutral | ¥21.57B | 12.44 | ― | 4.44% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Harima Chemicals Group, Inc. reported an 8% increase in net sales for the first quarter of the fiscal year ending March 31, 2026, compared to the same period in the previous year. Despite a rise in net sales and operating income, the company experienced a decrease in comprehensive income, highlighting potential challenges in maintaining profitability. The financial forecast for the full fiscal year anticipates a 6.9% increase in net sales and a significant rise in net income, indicating optimistic expectations for future growth.